228 related articles for article (PubMed ID: 28751189)
1. Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors.
Charmsaz S; Scott AM; Boyd AW
Exp Hematol; 2017 Oct; 54():31-39. PubMed ID: 28751189
[TBL] [Abstract][Full Text] [Related]
2. Natural products as exquisitely potent cytotoxic payloads for antibody- drug conjugates.
Gromek SM; Balunas MJ
Curr Top Med Chem; 2015; 14(24):2822-34. PubMed ID: 25487009
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic monoclonal antibodies for hematological diseases].
Harada T; Abe M
Nihon Rinsho; 2014 Jun; 72(6):1143-8. PubMed ID: 25016818
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies targeting CD38 in hematological malignancies and beyond.
van de Donk NW; Janmaat ML; Mutis T; Lammerts van Bueren JJ; Ahmadi T; Sasser AK; Lokhorst HM; Parren PW
Immunol Rev; 2016 Mar; 270(1):95-112. PubMed ID: 26864107
[TBL] [Abstract][Full Text] [Related]
5. EPHA3 as a novel therapeutic target in the hematological malignancies.
Keane N; Freeman C; Swords R; Giles FJ
Expert Rev Hematol; 2012 Jun; 5(3):325-40. PubMed ID: 22780212
[TBL] [Abstract][Full Text] [Related]
6. [Design of next generation antibody drug conjugates].
Zhu GD; Fu YX
Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
[TBL] [Abstract][Full Text] [Related]
7. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.
de Weers M; Tai YT; van der Veer MS; Bakker JM; Vink T; Jacobs DC; Oomen LA; Peipp M; Valerius T; Slootstra JW; Mutis T; Bleeker WK; Anderson KC; Lokhorst HM; van de Winkel JG; Parren PW
J Immunol; 2011 Feb; 186(3):1840-8. PubMed ID: 21187443
[TBL] [Abstract][Full Text] [Related]
8. Antibody Therapies in Cancer.
Wang S; Jia M
Adv Exp Med Biol; 2016; 909():1-67. PubMed ID: 27240456
[TBL] [Abstract][Full Text] [Related]
9. [Monoclonal antibody therapy: a literature review].
Del Debbio CB; Tonon LM; Secoli SR
Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic monoclonal antibodies in hemato-oncology].
Gennigens C; Collignon J; Jerusalem G; Rorive A; Sautois B
Rev Med Liege; 2009; 64(5-6):264-7. PubMed ID: 19642456
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond.
Katz BZ; Herishanu Y
Leuk Lymphoma; 2014 May; 55(5):999-1006. PubMed ID: 23885836
[TBL] [Abstract][Full Text] [Related]
12. Gpnmb/osteoactivin, an attractive target in cancer immunotherapy.
Zhou LT; Liu FY; Li Y; Peng YM; Liu YH; Li J
Neoplasma; 2012; 59(1):1-5. PubMed ID: 22017590
[TBL] [Abstract][Full Text] [Related]
13. Eph receptors as cancer targets for antibody-based therapy.
Tang FHF; Davis D; Arap W; Pasqualini R; Staquicini FI
Adv Cancer Res; 2020; 147():303-317. PubMed ID: 32593404
[TBL] [Abstract][Full Text] [Related]
14. Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches.
Jurcic JG; Cathcart K; Pinilla-Ibarz J; Scheinberg DA
Curr Opin Hematol; 2000 Jul; 7(4):247-54. PubMed ID: 10882181
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Therapeutic Antitumor Monoclonal Antibodies.
Tsao LC; Force J; Hartman ZC
Cancer Res; 2021 Sep; 81(18):4641-4651. PubMed ID: 34145037
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology.
Mihăilă RG
Recent Pat Anticancer Drug Discov; 2020; 15(4):272-292. PubMed ID: 32981510
[TBL] [Abstract][Full Text] [Related]
17. [An overview of antibody therapy against cancer].
Taniguchi H; Imai K
Nihon Rinsho; 2012 Dec; 70(12):2087-92. PubMed ID: 23259378
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies as therapeutics in human malignancies.
Pandey M; Mahadevan D
Future Oncol; 2014 Mar; 10(4):609-36. PubMed ID: 24754592
[TBL] [Abstract][Full Text] [Related]
19. The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment.
Buckens OJ; El Hassouni B; Giovannetti E; Peters GJ
Expert Opin Investig Drugs; 2020 Jun; 29(6):567-582. PubMed ID: 32348169
[TBL] [Abstract][Full Text] [Related]
20. Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodies.
Capietto AH; Keirallah S; Gross E; Dauguet N; Laprévotte E; Jean C; Gertner-Dardenne J; Bezombes C; Quillet-Mary A; Poupot M; Ysebaert L; Laurent G; Fournié JJ
Curr Drug Targets; 2010 Jul; 11(7):790-800. PubMed ID: 20370648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
